Quality Systems – Page 261

Pet Failure at accelerated stability: packaging integrity and stability justification

Addressing Packaging Integrity and Stability Justification Issues in Pet Products During Accelerated Stability Tests In the realm of pharmaceutical manufacturing, particularly within dosage forms such as otic formulations, identifying and…

E&L Failure after supplier change: packaging compatibility and shelf-life justification

Addressing E&L Failures Following Supplier Adjustments in Pharmaceutical Manufacturing The pharmaceutical sector is no stranger to challenges, particularly when it comes to ensuring the compatibility of packaging materials with drug…

Viscosity Drift during bulk hold: GMP investigation steps with CAPA

Addressing Viscosity Drift Issues During Bulk Hold: An Investigation Framework Viscosity drift during bulk hold poses significant challenges in pharmaceutical manufacturing, particularly for dosage forms such as dental preparations. Deviations…

Hold Time Bioburden Rise after supplier change: manufacturing vs lab root cause decision tree

Investigation of Hold Time Bioburden Increase Following Supplier Change: A Decision Tree Approach The rise in bioburden levels observed during hold time after changing a supplier can pose significant concerns…

Viscosity Drift in dental gel manufacturing: packaging compatibility and shelf-life justification

Investigation into Viscosity Drift in Dental Gel Manufacturing: Ensuring Packaging Compatibility and Shelf-Life Justification Viscosity drift during the manufacturing of dental gels poses a significant challenge in maintaining product quality…

Phase Separation after supplier change: manufacturing vs lab root cause assessment

Investigating Phase Separation after a Change in Supplier: A Manufacturing and Laboratory Perspective Phase separation is a critical issue in pharmaceutical manufacturing, particularly when a change in supplier occurs. This…

Content Uniformity Failure after packaging change: packaging compatibility and shelf-life justification

Addressing Content Uniformity Failure Following a Packaging Change: An Investigation Approach In pharmaceutical manufacturing, ensuring consistent content uniformity is paramount, especially following changes to packaging. A deviation in content uniformity…

Fill Volume Variability during method transfer: manufacturing vs lab root cause decision tree

Addressing Variability in Fill Volume during Method Transfer: A Root Cause Investigation Framework Variability in fill volume during method transfer poses significant compliance and product quality challenges in pharmaceutical manufacturing.…

Tube Leakage Complaint in dental paste filling: sampling and mixing controls for QA review

Investigating Tube Leakage Complaints in Dental Paste Filling: A Practical Approach for QA Review Tube leakage complaints in dental paste filling operations can have significant implications for product quality and…

Assay Oos in dental paste filling: packaging compatibility and shelf-life justification

Investigation of Out-of-Specification Assays in Dental Paste Filling: Ensuring Packaging Compatibility and Shelf-Life Justification In the pharmaceutical manufacturing sector, particularly in the production of dental dosage forms, the emergence of…

Sedimentation Oos during inspection readiness: packaging integrity and stability justification

Addressing Sedimentation OOS during Inspection Readiness: Understanding Packaging Integrity and Stability In the realm of pharmaceutical manufacturing, especially within dosage forms like otic solutions, variations in sedimentation can trigger out-of-specification…

Pet Failure in dental paste filling: GMP investigation steps with CAPA

Addressing Pet Failures in Dental Paste Filling: A Comprehensive GMP Investigation Guide In the fast-paced world of pharmaceutical manufacturing, especially within dental dosage forms, encountering problems like pet failure during…